Identification of exacerbations in obstructive lung disease through biomarkers

References

• Andenaes R, Kalfoss MH. (2004). Psychological distress in hospitalized patients with chronic obstructive pulmonary disease. Eur J Epidemiol 19:851–9.
   PubMed Web of Science ®Google Scholar
• Anonymous. (2007). ATC Classification index with DDDs 2007. Nydalen: WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health.
   Google Scholar
• Baibergenova A, Thabane L, Akhtar–Danesh N, Levine M, Gafni A, Moineddin R, Pulcins I. (2005). Effect of gender, age, and severity of asthma attack on patterns of emergency department visits due to asthma by month and day of the week. Eur J Epidemiol 20:947–56.
   PubMed Web of Science ®Google Scholar
• Barnes P, Adcock I. (2003). How do corticosteroids work in asthma? Ann Intern Med 139:359–70.
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95.
   PubMed Web of Science ®Google Scholar
• Blais L, Ernst P, Boivin JF, Suissa S. (1998). Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 158:126–32.
   PubMed Web of Science ®Google Scholar
• Blais L, Lemière C, Menzies D, Berbiche D. (2006). Validity of asthma diagnoses recorded in the Medical Services database of Quebec. Pharmacoepidemiol Drug Saf 15:245–52.
   PubMed Web of Science ®Google Scholar
• Boyter AC, Steinke DT. (2005). Changes in prescribing of inhaled corticosteroids (1999–2002) in Scotland. Pharmacoepidemiol Drug Saf 14:203–9.
   PubMedGoogle Scholar
• Califf RM, Ginsburg GS. (2008). Organizational improvements to enhance modern clinical epidemiology. JAMA 300:2300–2.
   PubMedGoogle Scholar
• Chakraborty A, Blum RA, Cutler DL, Jusko WJ. (1999). Pharmacoimmunodynamic interactions of interleukin-10 and prednisone in healthy volunteers. Clin Pharmacol Ther 65:304–18.
   PubMedGoogle Scholar
• Cho H, Kim JH. (2009). Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer. Biomarkers 14:161–70.
   PubMed Web of Science ®Google Scholar
• Chung K, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, Bel E, Burney P, Chanez P, Connett G, Corrigan C, De Blic J, Fabbri L, Holgate S, Ind P, Joos G, Kerstjens H, Leuenberger P, Lofdahl C-G, McKenzie S, Magnussen H, Postma D, Saetta M, Salmeron S, Silverman M, Sterk P. (1999). Difficult/therapy-resistant asthma. The need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-resistant asthma. Eur Respir J 13:1198–208.
   PubMed Web of Science ®Google Scholar
• Czock D, Keller F, Rasche F, Häussler U. (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44:61–98.
   PubMed Web of Science ®Google Scholar
• Douwes J, Gibson P, Pekkanen J, Pearce N. (2002). Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57:643–8.
   PubMed Web of Science ®Google Scholar
• Franciosi LG, Page CP, Celli BR, Cazzola M, Walker MJ, Danhof M, Rabe KF, Della Pasqua OE. (2006). Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 19:189–99.
   PubMed Web of Science ®Google Scholar
• GINA. (2008). From the Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA). Available from: http://www.ginasthma.org [last accessed 13 July 2009].
   Google Scholar
• GOLD. (2008). From the Global Strategy for the Diagnosis Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available from: http://www.goldcopd.org [last accessed 13 July 2009].
   Google Scholar
• Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. (2002). Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57:875–9.
   PubMed Web of Science ®Google Scholar
• Jatakanon A, Uasuf C, Maziak W, Lim S, Chung K, Barnes P. (1999). Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 160:1532–9.
   PubMed Web of Science ®Google Scholar
• Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. (2000). The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 161:9–16.
   PubMed Web of Science ®Google Scholar
• Mahajan B, Vijayan VK, Agarwal MK, Bansal SK. (2008). Serum interleukin-1beta as a marker for differentiation of asthma and chronic obstructive pulmonary disease. Biomarkers 13:713–27.
   PubMed Web of Science ®Google Scholar
• Movig KL, Leufkens HG, Lenderink AW, Egberts AC. (2003). Validity of hospital discharge International Classification of Diseases (ICD) codes for identifying patients with hyponatremia. J Clin Epidemiol 56:530–5.
   PubMed Web of Science ®Google Scholar
• Pauwels RA. (2004). Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc 1:73–6.
   PubMedGoogle Scholar
• Roede BM, Bresser P, Bindels PJ, Kok A, Prins M, ter Riet G, Geskus RB, Herings RM, Prins JM. (2008). Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study. Thorax 63:968–73.
   PubMed Web of Science ®Google Scholar
• Steele RW, Steele CR, Pilkington NS Jr, Charlton RK. (1987). Functional capacity of marginated and bone marrow reserve granulocytes. Infect Immun 55:2359–63.
   PubMedGoogle Scholar
• Sutherland ER. (2004). Outpatient treatment of chronic obstructive pulmonary disease: comparisons with asthma. J Allergy Clin Immunol 114:715–24.
   PubMed Web of Science ®Google Scholar
• Ten Berg MJ, Huisman A, van den Bemt PM, Schobben AF, Egberts AC, van Solinge WW. (2007). Linking laboratory and medication data: new opportunities for pharmacoepidemiological research. Clin Chem Lab Med 45:13–19.
   PubMedGoogle Scholar
• Valet G. (2006). Cytomics as a new potential for drug discovery. Drug Discov Today 11:785–91.
   PubMed Web of Science ®Google Scholar
• Van Ganse E, van der Linden PD, Leufkens HG, Herings RM, Vincken W, Ernst P. (1995). Asthma medications and disease exacerbations: an epidemiological study as a method for asthma surveillance. Eur Respir J 8:1856–60.
   PubMedGoogle Scholar
• Velthove KJ, van Solinge WW, Lammers JW, Leufkens HG, Schweizer RC, Bracke M. (2009). Hematocytometry analysis as discriminative marker for asthma phenotypes. Clin Chem Lab Med 47:573–8.
   PubMed Web of Science ®Google Scholar
• Wenzel S, Fahy J, Irvin C, Peters S, Spector S, Szefler S. (2000). Proceedings of the ATS workshop on refractory asthma. Current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 162:2341–51.
   PubMedGoogle Scholar
• Wild N, Karl J, Grunert VP, Schmitt RI, Garczarek U, Krause F, Hasler F, van Riel PL, Bayer PM, Thun M, Mattey DL, Sharif M, Zolg W. (2008). Diagnosis of rheumatoid arthritis: multivariate analysis of biomarkers. Biomarkers 13:88–105.
   PubMed Web of Science ®Google Scholar
• Zhang X, Moilanen E, Kankaanranta H. (2001). Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis. Eur J Pharmacol 431:365–71.
   PubMed Web of Science ®Google Scholar